Recent studies have examined the therapeutic benefits of cannabidiol (CBD), a non-intoxicating compound found in cannabis, especially concerning its potential influence on anxiety disorders. The research article published in Psychopharmacology delves into CBD’s effects on fear conditioningβa process critical to the development and maintenance of anxiety disorders. Researchers focused on Read more…
Cannabidiol (CBD), a non-intoxicating compound found in cannabis, has gained significant attention for its potential therapeutic effects. Notably, its impact on inflammatory processes in the context of stroke has become a focal point in medical research. A recent study, published in Experimental Neurology, sheds light on the intricate mechanisms behind Read more…
Cannabidiol (CBD), a non-psychoactive compound found in cannabis, has garnered attention for its potential health benefits in humans and pets alike. A recent study, titled “Long-term effect of oral cannabidiol administration to healthy adult dogs on tear production, intraocular pressure, and tear concentrations”, explores the impact of sustained CBD use Read more…
Researchers are initiating a landmark clinical trial to discover the potential benefits of cannabidiol (CBD) as an adjunctive therapy for individuals experiencing early psychosis. This randomized controlled trial, detailed in the study protocol, aims to assess the efficacy and safety of CBD when used alongside standard antipsychotic treatments. The trial Read more…
As the acceptance and use of cannabis and cannabinoids continue to grow, nephrologists and healthcare providers face the challenge of understanding the implications these substances have on kidney health. A comprehensive guide published by Rein, “The Nephrologist’s Guide to Cannabis and Cannabinoids”, sheds light on the intricacies of cannabis as Read more…
The study of cannabis and cannabinoids has become increasingly relevant in the medical community, especially concerning their effects on stroke patients. This comprehensive review delves into the complexities surrounding the use of these substances in the context of cerebral ischemia and stroke. It scrutinizes the controversies, risks, and promising therapeutic Read more…
The study titled “A Research Domain Criteria Approach to Gambling Disorder and Behavioral Addictions: Decision-Making, Response Inhibition, and the Role of Cannabidiol” presents a detailed analysis within the Research Domain Criteria (RDoC) framework of neuropsychiatric disorders. This pioneering approach examines the cognitive facets of gambling disorder (GD) and various behavioral Read more…
Fibrosis is a pathological condition characterized by the excessive accumulation of fibrous connective tissue, leading to the scarring of organs such as the skin and liver. Recent research published in Frontiers in Pharmacology presents promising evidence that cannabidiol (CBD), a non-psychoactive compound derived from the Cannabis sativa plant, could be Read more…
Epilepsy affects millions worldwide, presenting a variety of subtypes, each with unique challenges. The search for effective treatments has been at the forefront of medical research. A recent study, titled “Realβworld data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter study,” offers valuable insights into the use of Read more…
A groundbreaking study published in the National Institutes of Health (NIH) examines the repercussions of ultraviolet (UV) radiation on rat blood and how cannabidiol (CBD) can potentially offer protection against the oxidative damage it causes. Ultraviolet radiation, commonly known from sunlight overexposure, can lead to oxidative stressβa condition where thereβs Read more…